Biogen Idec

Biogen Idec

Biogen Idec, Inc. is an American biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego, California-based IDEC Pharmaceuticals . Biogen, one of the oldest biotechnology companies, was founded in 1978 in Geneva by several biologists, including Phillip Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard and Charles Weissmann of Zurich University . Biogen Idec stock is a component of several stock indices such as...
more

quick facts
NASDAQ symbol:BIIB
Founded:2003
Headquarters:Cambridge, Massachusetts
Annual revenue:$4,097,510,000
Net income:$783,170,000
Operating income:$874,800,000
Market cap:$17,000,000,000
Industries:Biotechnology, Biological Product (except Diagnostic) Manufacturing

Revenue history for Biogen Idec

RevenueDate
$4,097,510,000 December 31, 2008
$2,683,000,000 December 31, 2006
« Prev  Next »

Net income history for Biogen Idec

Net IncomeDate
$783,170,000 December 31, 2008
« Prev  Next »

Headquarters of Biogen Idec

Cambridge
Cambridge
Founded:1630
Population:105,162

Cambridge is a city in Middlesex County, Massachusetts, United States, in the Greater Boston area. It was named in honor of the University of Cambridge in England, an important center of the Puritan theology embraced by the town's founders. Cambridge is home to two of the world's most prominent...
more

Current Biogen Idec board members

Mary L. Good
Mary L. Good

Mary Lowe Good is an inorganic chemist who does industrial research and has worked in government. She received her BS from the University of Central...
more

Eckhard Pfeiffer
Eckhard Pfeiffer
Board member since:2002

Eckhard Pfeiffer is a businessman of German ancestry, who served as President and CEO of Compaq from 1991 to 1999. He was named as one of TIME's...
more

Divisions of Biogen Idec

Division Name
Biogen Idec Realty Partnership
Syntonix Pharmaceuticals, Inc
Biotech Manufacturing CV
Biogen Idec Australia PTY Ltd
Biogen Idec Realty Corporation
Biogen Idec Norway AS
Biogen Idec U.S. Partnership
Biogen Idec promet s farmacevtskimi in biotehnoloskimi proizvodi d.o.o
Biogen Idec (Czech Republic) s.r.o.
Biogen Idec Belgium N.V.
Biogen Idec Portugal Sociedade Farmaceutica, Unipessoal, Lda
Biogen Idec Foundation Inc
Biogen Idec Ltd
Biogen Idec (Denmark) Manufacturing ApS
Biogen Idec Holding APS
Eidetica Biopharma GmbH
Biogen Idec Biotech India Pvt. Ltd
Biogen Idec U.S. West Corp
Biogen Dompe AG
Biogen Idec Canada Inc
Biogen Idec (Slovak Republic) s.r.o.
Biogen Idec France S.A.S.
Biogen Idec Holding I Inc
Biogen Idec Mexico S. DE R.L. DE C.V.
CONFORMA THERAPEUTICS CORP
Biogen Idec K
Biogen Idec Holding II Inc
Biogen Idec International B.V.
Biogen Idec U.S. Corp
Biogen Idec Austria GmbH
Biogen Idec Sweden AB
Biogen Idec NZ Ltd
Biogen Idec Realty LLC
Biogen Idec International GmbH
Biogen Idec (Denmark) A/S
Biogen Idec Brazil Produtos Farmaceuticos LTDA
Biogen Inc.
Biogen Idec GmbH
Biogen Idec Iberia SL
Biogen Idec U.S. Pacific LLC
BiogenIdec Sweden AB
Biogen Idec (Argentina) SRL
Biogen Idec (Ireland) Ltd
Biogen Idec Finland OY
Biogen Idec Japan Ltd
Biogen Idec Nobel Research Center, LLC
Biogen Dompe SRL
Biogen Idec SRO Inc
Biogen Idec B.V.
« Prev  Next »

Other companies in the same city as Biogen Idec

Genzyme
Genzyme
Revenue: $4,605,040,000
Akamai Technologies
Akamai Technologies
Revenue: $790,920,000
Sapient
Sapient
Revenue: $687,490,000
Millennium Pharmaceuticals
Millennium Pharmaceuticals
Revenue: $486,800,000
Mac-Gray Corporation
Mac-Gray Corporation
Revenue: $363,590,000
Alkermes Inc.
Alkermes Inc.
Revenue: $326,840,000
Aspen Technology
Aspen Technology
Revenue: $293,100,000
Forrester Research
Forrester Research
Revenue: $240,880,000
Pegasystems Inc.
Pegasystems Inc.
Revenue: $211,650,000
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Revenue: $175,500,000
Art Technology Group
Art Technology Group
Revenue: $164,640,000
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Revenue: $96,160,000

Frequently Asked Questions

  • Q:
    When was Biogen Idec founded?
  • A:
    The business was founded in 2003.
  • Q:
    Which sectors does Biogen Idec operate?
  • A:
    The company operates in Biotechnology and Biological Product (except Diagnostic) Manufacturing.
  • Q:
    What is the stock symbol and stock exchange for Biogen Idec?
  • A:
    The company's stock symbol is "BIIB" listed on the NASDAQ stock exchange.
  • Q:
    What location is the corporate headquarters of Biogen Idec?
  • A:
    The main office is located in Cambridge, Massachusetts.
  • Q:
    What are the names of the board members at Biogen Idec?
  • A:
    Some Members of the Board include:
    - Bruce Ross, Board Member
    - Cecil B Pickett, Board Member
    - James C Mullen, Board Member
    - Lawrence C Best, Board Member
    - Marijn E Dekkers, Board Member
    - Thomas F Keller, Board Member
    - Alan Belzer, Board Member
    - Mary L. Good, Board Member
    - Philip A Sharp, Board Member
    - Eckhard Pfeiffer, Board Member

Lists

Biogen Idec
Top of Page © 2012 Juggle, LLC
All Rights Reserved
Encyclopedia & Reference Resource
Some of the content on this page was provided by other sites, including
Freebase Icon (Biogen Idec) or others licensed under Creative Commons